Michael P. Bailey - Sep 1, 2021 Form 4 Insider Report for AVEO PHARMACEUTICALS, INC. (AVEO)

Role: President & CEO, Director
Signature: /s/ Danielle Holland, attorney-in-fact
Stock symbol: AVEO
Transactions as of: Sep 1, 2021
Transactions value $: $97,200
Form type: 4
Date filed: 9/3/2021, 05:12 PM
Next filing: Feb 17, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AVEO	Common Stock	Purchase	$97.2K	+15K	+43.72%	$6.48	49.3K	Sep 1, 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.45 to $6.49, inclusive. The reporting person undertakes to provide to AVEO, any security holder of AVEO, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
F2	Includes 2,426 shares acquired under AVEO's 2010 Employee Stock Purchase Plan.

Content

The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.45 to $6.49, inclusive. The reporting person undertakes to provide to AVEO, any security holder of AVEO, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.

Includes 2,426 shares acquired under AVEO's 2010 Employee Stock Purchase Plan.